Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 34
Summary
- Conditions
- Extensive Stage Small Cell Lung Cancer
- Small Cell Lung Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03913455
- Collaborators
- Astex Pharmaceuticals, Inc.
- Indiana University School of Medicine
- Investigators
- Principal Investigator: Shadia Jalal, MD, MBBS Indiana University School of Medicine
Get Well Soon